Chemical Compound

levonordefrin

CAS Registry Number 829-74-3
levonordefrin chemical structure
Primary Record

levonordefrin

In stock
7,713 g
Purity
98.9 %
CAS
829-74-3

Compound Identifiers & Properties

CAS
829-74-3
PubChem CID
164739
SMILES
C[C@@H]([C@@H](C1=CC(=C(C=C1)O)O)O)N
Canonical SMILES
C[C@H](N)[C@H](O)c1ccc(O)c(O)c1

Names & Synonyms

  • levonordefrin
  • Corbadrine
  • Neo-Cobefrin
  • Nordefrin
  • Corbadrina
  • Corbadrinum
  • Isoadrenaline
  • L-Nordefrin
  • levoepinefrina
  • Corbadrin
  • alpha-Methylnoradrenaline
  • (-)-cobefrin
  • l-Cobefrin
  • Nordefrin, l-
  • NeoCobefrin
  • Dl-corbadrine
  • Neo Cobefrin
  • Corbadrine [INN]
  • Methylnoradrenaline
  • 829-74-3
  • alpha-Me-NE
  • Levonordefrin (USP)
  • Levonordefrin [USP]
  • Nordefrin (-)-form
  • Nordefrin, (-)-
  • LevonordefrinCorbadrine
  • Corbadrine (INN)
  • L-alpha-Methylnoradrenaline
  • Levonordefrin [USAN]
  • alpha-Methylnorepinephrine
  • Corbadrinum [INN-Latin]
  • Neo-cobefrin (TN)
  • Nordefrin (-)-
  • Corbadrina [INN-Spanish]
  • |A-methylnoradrenaline
  • 3,4-Dihydroxynorephedrin
  • Spectrum_001642
  • NORDEFRIN [MI]
  • Levonordefrin (Standard)
  • 2,3,4-Trifluoroaniline
  • Prestwick3_000739
  • RefChem:799029
  • Spectrum2_001055
  • Spectrum3_000480
  • Spectrum4_000032
  • Spectrum5_000912
  • C9H13NO3
  • Lopac-D-5290
  • (-)-3,4-Dihydroxynorephedrine
  • BA 2818
  • DTXSID6046349
  • L-.alpha.-methylnoradrenaline
  • CHEMBL677
  • D0E9VU
  • Epitope ID:768775
  • L-norephedrine, 3,4-dihydroxy-
  • -3,4-Dihydroxynorephedrine
  • AC1L4VD7
  • CORBADRINE [MART.]
  • NORDEFRIN [WHO-DD]
  • CHEBI:141146
  • CORBADRINE [WHO-DD]
  • (R-(R*,S*))-isomer
  • (+/-)-COBEFRIN
  • BSPBio_000698
  • BSPBio_002220
  • DTXCID4026349
  • GTPL508
  • KBioGR_000463
  • KBioSS_002122
  • LEVONORDEFRIN [VANDF]
  • UNII-R81X549E70
  • UNII-V008L6478D
  • CHEBI:10304
  • (-)-alpha-Methylnoradrenaline
  • 4-[(1R,2S)-2-amino-1-hydroxypropyl]benzene-1,2-diol
  • DivK1c_000315
  • NSC-757084
  • SCHEMBL119171
  • SPECTRUM1500365
  • SPBio_001010
  • (-)3,4-Dihydroxynorephedrine
  • LEVONORDEFRIN [USP-RS]
  • BPBio1_000768
  • SCHEMBL29410156
  • V008L6478D
  • BA-2818
  • ERK5-4O15
  • HMS500P17
  • KBio1_000315
  • KBio2_002122
  • KBio2_004690
  • KBio2_007258
  • KBio3_001440
  • ZINC34157
  • (-)-3,4-Dihydroxy Norephedrine
  • GEFQWZLICWMTKF-CDUCUWFYSA-N
  • NINDS_000315
  • HMS1920J07
  • HMS2091P13
  • HMS2097C20
  • HMS3714C20
  • Pharmakon1600-01500365
  • LEVONORDEFRIN [ORANGE BOOK]
  • NORDEFRIN (-)-FORM [MI]
  • R81X549E70
  • C9-H13-N-O3
  • 4-(2-amino-1-hydroxypropyl)benzene-1,2-diol
  • Tox21_112051
  • BDBM50223426
  • CCG-40121
  • CID164739
  • EBC-26157
  • LEVONORDEFRIN [USP MONOGRAPH]
  • MFCD00134415
  • NSC757084
  • CAS-829-74-3
  • AKOS006280500
  • Tox21_112051_1
  • (-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl alcohol
  • DB06707
  • HY-107915R
  • J7.129C
  • NSC 757084
  • IDI1_000315
  • NCGC00015345-01
  • NCGC00016542-01
  • NCGC00016542-02
  • NCGC00016542-03
  • NCGC00016542-04
  • NCGC00016542-05
  • NCGC00016542-06
  • NCGC00163349-01
  • MS-22982
  • ST049172
  • (1r,2s)-(-)-3,4-dihydroxynorephedrine
  • SBI-0051428.P003
  • HY-107915
  • LS-177715
  • AB00513909
  • alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl alcohol
  • CS-0030862
  • NS00068182
  • C11768
  • D02388
  • F82166
  • 829-74-3, 18829-78-2 [replaced]
  • AB00052030_04
  • 4-((1R,2S)-2-amino-1-hydroxypropyl)benzene-1,2-diol
  • 4-[(1R,2S)-2-Amino-1-hydroxypropyl]-1,2-benzenediol
  • 829D743
  • SR-05000002090
  • A1205263
  • SR-05000002090-1
  • SR-05000002090-2
  • BRD-K02976377-001-07-4
  • BRD-K02976377-001-08-2
  • erythro-(-)-alpha-(1-Aminoethyl)-3,4-dihydrobenzyl alcohol
  • I14-45238
  • Q12745763
  • (1R,2S)-2-Amino-1-(3,4-dihydroxyphenyl)-1-propanol
  • 4-((2S,1R)-2-amino-1-hydroxypropyl)benzene-1,2-diol
  • 74812-63-8
  • 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-, (R-(R*,S*))-
  • 4-[(1R,2S)-2-amino-1-hydroxy-propyl]benzene-1,2-diol
  • Benzyl alcohol, .alpha.-(1-aminoethyl)-3,4-dihydroxy-, erythro-(-)-
  • (+/-)-GA-(1-AMINOETHYL)-3,4-DIHYDROXYBENZYL ALCOHOL
  • (-)-4-[(1R,2S)-2-Amino-1-hydroxypropyl]-1,2-benzenediol
  • (-)-.ALPHA.-(1-AMINOETHYL)-3,4-DIHYDROXYBENZYL ALCOHOL
  • 1,2-BENZENEDIOL, 4-((1R,2S)-2-AMINO-1-HYDROXYPROPYL)-
  • 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-, [R-(R*,S*)]-
  • 1,2-Benzenediol, 4-(2-amino-1-hydroxypropyl)-,(R-(R*,S*))-
  • Levonordefrin, United States Pharmacopeia (USP) Reference Standard
  • 1,2-BENZENEDIOL, 4-((1R,2S)-2-AMINO-1-HYDROXYPROPYL)-, REL-
  • 1,2-BENZENEDIOL, 4-(2-AMINO-1-HYDROXYPROPYL)-, (R*,S*)-(+/-)-
  • 1,2-BENZENEDIOL, 4-(2-AMINO-1-HYDROXYPROPYL)-, (R-(R*,S*))
  • BENZYL ALCOHOL, .ALPHA.-(1-AMINOETHYL)-3,4-DIHYDROXY-, ERYTHRO-(+/-)-
  • Corbadrine; D-(-)-Cobefrin; L--Methylnoradrenaline; Levonordefrin; Neo-cobefrin; l-Cobefrin; l--(1-Aminoethyl)-3,4-dihydroxybenzyl alcohol